Bay Area

April 25, 2023- Addressing the Development & Manufacturing Challenges of Cell & Gene Therapies

   


September 8, 2022- Current & Future State of M&A

   Darcy Mootz, Head, Amunix Pharmaceuticals

   Jay Stamatis, VP & Head of BD & Acquisitions, AbbVie

   Julianne Averill, CFO consultant, Danforth Advisors

   Lori Hu, Managing Director, Vertex Ventures HC

   Moderated by Samina Bari, Strategic Business Advisor, Cayuga Biotech


May 24, 2022- Status of the Industry

   Anne Longmire, VP, JP Morgan

   Brent Vaughan, CEO, Cognito Therapeutics

   Mike Guerra, CEO, CA Life Sciences

   Shelley Chu, Partner, Lightspeed Venture Partners

   Moderated by Ben Conway, consultant, Danforth Advisors